Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pancreatic cancer
pancreatic cancer
TESARO Describes Initial Phase 1 Clinical Data for TSR-011 Presented at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Sun, 09/29/13 - 01:35 pm
TSR-011
pancreatic cancer
Tesaro
1 Drug Dramatically Reshaping Pancreatic Cancer Treatment
Motley Fool
Sat, 09/14/13 - 11:00 am
Celgene Corporation
Abraxane
pancreatic cancer
1 Drug Dramatically Reshaping Pancreatic Cancer Treatment
Motley Fool
Fri, 09/13/13 - 08:27 am
Celgene
pancreatic cancer
Abraxane
F.D.A. Approves a Drug for Late-Stage Pancreatic Cancer
NY Times
Sat, 09/7/13 - 11:45 am
Abraxane
Celgene
pancreatic cancer
Merrimack Progresses With MM-398
Yahoo/Zacks
Fri, 08/30/13 - 08:45 am
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Pop-Worthy Data, Incyte, but Let's See More
Motley Fool
Sat, 08/24/13 - 11:42 am
Incyte
Jakafi
pancreatic cancer
Merrimack Study Data Published
Yahoo/Zacks
Sat, 08/24/13 - 11:36 am
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Does Incyte Deserve Its New Valuation?
Motley Fool
Thu, 08/22/13 - 09:14 am
Incyte
JAK inhibitors
Jakafi
pancreatic cancer
Incyte pancreatic cancer drug improves survival in mid-stage trial
Reuters
Wed, 08/21/13 - 10:18 am
Incyte
pancreatic cancer
Jakafi
Celgene’s Abraxane: A Therapy for Advanced Pancreatic Cancer?
Motley Fool
Mon, 06/10/13 - 10:56 am
Celgene
Abraxane
pancreatic cancer
Novartis
Pfizer
3 Stocks to Watch Ahead of ASCO
Motley Fool
Tue, 05/28/13 - 06:28 pm
cancer
ASCO
nivolumab
Bristol-Myers Squibb
idelalisad
Gilead
PEGPH20
Halozyme
pancreatic cancer
New Pancreatic Cancer Drug an FDA Priority
Motley Fool
Sun, 05/26/13 - 11:20 am
pancreatic cancer
Celgene
Abraxane
Halozyme rises on pancreatic cancer drug study
Yahoo/AP
Thu, 05/16/13 - 05:30 pm
pancreatic cancer
Halozyme
PEGPH20
Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Bloomberg
Thu, 03/14/13 - 11:15 am
pancreatic cancer
diabetes
Merck
Januvia
Bristol-Myers Squibb
Byetta
Novo Nordisk
Victoza
Peregrine's Epic Failure (Maybe)
Motley Fool
Fri, 02/15/13 - 11:42 am
Peregrine Pharmaceuticals
pancreatic cancer
bavituximab
3 Events Biotech Investors Need to Watch in 2013
Motley Fool
Thu, 02/14/13 - 10:28 am
Vical
Allovectin
metastatic melanoma
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Afrezza
diabetes
MannKind
Peregrine Pharma Is Wasting Money On A Placebo Cancer Drug
TheStreet.com
Wed, 02/13/13 - 11:00 am
Peregrine Pharmaceuticals
bavituximab
pancreatic cancer
Celgene’s Abraxane Benefits Pancreatic Cancer Patients
Bloomberg
Wed, 01/23/13 - 10:40 am
Celgene
Abraxane
pancreatic cancer
3 Things to Watch at Merrimack
Motley Fool
Sun, 12/30/12 - 12:12 pm
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
MM-121
breast cancer
lung cancer
Does Merrimack Pharmaceuticals Have A Blockbuster Drug With MM-398?
Seeking Alpha
Thu, 12/6/12 - 05:32 pm
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »